Role of wild type p53 and double suicide genes in interventional therapy of liver cancer in rabbits

被引:11
作者
Niu, Hong-xin [1 ]
Du, Tong [1 ]
Xu, Zhong-fa [1 ]
Zhang, Xi-kun [1 ]
Wang, Ruo-gu [1 ]
机构
[1] Shandong Acad Med Sci, Affiliated Hosp, Dept Gen Surg, Jinan 250031, Peoples R China
关键词
Liver Neoplasms; Genes; p53; Gene Therapy; Rabbits; TUMOR; SHRNA;
D O I
10.1590/S0102-86502012000800002
中图分类号
R61 [外科手术学];
学科分类号
摘要
PURPOSE: To investigate the feasibility of interventional lipiodol embolism and multigene therapy in combination with focal chemotherapy in the treatment of VX2 liver cancer in rabbits. METHODS: Forty five rabbits with cancer larger than 2cm in diameter were randomly divided into five groups (n=9 per group). In Group 1, animals were treated with 0.9% sodium chloride. In Group 2, animals received lipiodol embolism. In Group 3, animals received lipiodol embolism and p53 gene therapy. In Group 4, animals received lipiodol embolism and TK/CD gene therapy. In Group 5, animals received lipiodol embolism and p53 and TK/CD gene therapy. Ultrasonography and CT were performed before and at ten days after interventional therapy. RESULTS: The VX2 model of liver cancer was successfully established in rabbits and interventional therapy smoothly performed. At ten days after interventional therapy, significant difference in the tumor volume was noted among five groups (p<0.05) and different treatments could inhibit the cancer growth. The inhibition of cancer growth was the most evident in the Group 5. Factorial analysis revealed gene therapy with p53 or TK/CD and lipiodol embolism independently exert significantly inhibitory effect on cancer growth. In addition, the suppression on tumor growth rate was the most obvious in the Group 5. CONCLUSIONS: Combination of gene therapy with lipiodol embolism can effectively inhibit the cancer growth and prolong the survival time. These findings demonstrate the effectiveness of multigene therapy in combination with lipiodol embolism in the treatment of liver cancer.
引用
收藏
页码:522 / 528
页数:7
相关论文
共 16 条
  • [1] The p53 tumour suppressor protein
    Hickman, ES
    Helin, K
    [J]. BIOTECHNOLOGY & GENETIC ENGINEERING REVIEWS, VOL 17, 2000, 17 : 179 - 211
  • [2] Kesmodel Susan b., 2003, Expert Reviews in Molecular Medicine, V5, P1, DOI 10.1017/S1462399403006380
  • [3] Oncolytic Gene Therapy Combined with Double Suicide Genes for Human Bile Duct Cancer in Nude Mouse Models
    Kojima, Yoh
    Honda, Kazuo
    Hamada, Hirofumi
    Kobayashi, Nobuaki
    [J]. JOURNAL OF SURGICAL RESEARCH, 2009, 157 (01) : E63 - E70
  • [4] Enhanced antitumor effects by combination gene therapy using MDR1 gene shRNA and HSV1-tk in a xenograft mouse model
    Lee, Sang-Woo
    La Lee, You
    Lee, Yong Jin
    Park, Seung-Yoon
    Kim, In-San
    Choi, Tae Hyun
    Ha, Jeoung-Hee
    Ahn, Byeong-Cheol
    Lee, Jaetae
    [J]. CANCER LETTERS, 2010, 291 (01) : 83 - 89
  • [5] Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system
    Lemarie, Fanny
    Croft, Daniel R.
    Tate, Rothwelle J.
    Ryan, Kevin M.
    Dufes, Christine
    [J]. BIOMATERIALS, 2012, 33 (09) : 2701 - 2709
  • [6] Combination gene therapy using VEGF-shRNA and fusion suicide gene yCDglyTK inhibits gastric carcinoma growth
    Liu, Ting
    Ye, Ling
    He, Yongzheng
    Chen, Xuanmin
    Peng, Jie
    Zhang, Xiaomei
    Yi, Hong
    Peng, Fang
    Leng, Aimin
    [J]. EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2011, 91 (03) : 745 - 752
  • [7] Targeted killing effects of double CD and TK suicide genes controlled by survivin promoter on gastric cancer cell
    Luo, Xian-Run
    Li, Jian-Sheng
    Niu, Ying
    Miao, Li
    [J]. MOLECULAR BIOLOGY REPORTS, 2011, 38 (02) : 1201 - 1207
  • [8] Niu HX, 2007, CHIN J CURR ADV GEN, V10, P203
  • [9] Niu HX, 2007, CHIN J HEPATOB SURG, V13, P690
  • [10] TP53 and liver carcinogenesis
    Staib, F
    Hussain, SP
    Hofseth, LJ
    Wang, XW
    Harris, CC
    [J]. HUMAN MUTATION, 2003, 21 (03) : 201 - 216